Despite this evidence, IL-17C was shown to be upregulated in paradoxical psoriasis upon anti-TNF therapy in patients presenting inflammatory bowel disease (IBD), in a mechanisms depended on IL-36γ (99). Here, IL17C is linked to psoriasis.